LOADING...

← All case studies Case Study

Case Study: LRRK-2 Parkinson's Disease

We became the most cost-efficient recruitment channel for a rare LRRK2 Parkinson’s Disease trial, with 15X lower cost per randomized patient than social media, by turning genetic testing into a trusted community conversation.

15X lower cost per randomized than social media
28% referral-to-appointment rate vs. 2.2% industry benchmark
6.7X lower cost per consented than social media
2.5X more likely to randomize once referred than social-sourced patients

What changed

  • Ambassadors led conversations with relevant resources before introducing the study, then stayed with patients through at-home genetic kit ordering and site scheduling.
  • Patients felt welcomed into a Parkinson’s community, connected with peers who understand their experience, and that belonging motivated many to share the campaign with their own networks.
  • Outreach prioritized underserved geographies and patients already interested in genetics, reaching communities across 48 states that broad advertising never touched.

Before vs. WeHealth

Social media
Cost / referral
$11,011
Cost / consent
$51,750
Cost / randomized
$258,749
Sites
Cost / referral
$9,074
Cost / consent
$17,093
Cost / randomized
$35,000
WeHealth
Cost / referral
$1,809
Cost / consent
$7,727
Cost / randomized
$17,000

A precision recruitment funnel

Every inquiry was qualified, genetically confirmed, and supported all the way to the clinic.

  1. 756 Patient inquiries
  2. 328 Research study candidates
    43% of inquiries
  3. 47 LRRK2+ referrals to site
    14% of candidates, genetically confirmed
  4. 13 Appointments scheduled
    28% referral-to-appointment rate
  5. 11 Consented / in active screening
    85% of appointments
  6. 5 Randomized
    6 more consented and in screening

The work behind the numbers

Trust is built one conversation at a time.

8,816 call attempts
1,452 live patient conversations
284 hrs of coordinator call time
97.2% prescreener qualification rate
48 US states with active reach
17,142 messages sent
Problem

We partnered with a biotech company to recruit a rare genetic subset of Parkinson’s Disease patients for a Phase 2 clinical trial. Only about 3% of Parkinson’s Disease patients carry the targeted LRRK2 genetic marker, which made broad advertising inefficient and difficult to trust.

The sponsor needed qualified referrals from patients who were open to genetic testing and located in areas underserved by existing recruitment methods. Digital advertising could generate inquiries, but very few of them carried the genetic confirmation the study required.

Our approach

We engaged the Parkinson’s community by focusing on patients interested in genetics while prioritizing geographic areas underserved by existing recruitment methods, reaching active patients across 48 US states.

Patient coordinators led the conversations. Their initial goal was to relate to incoming patients, understand their needs, and connect them with resources that matched their journey. After establishing a connection and determining baseline eligibility, they shared information about the study and the genetic testing opportunity, then supported each patient through at-home genetic kits and site scheduling.

Those conversations built trust around genetic testing as a meaningful part of treatment planning. As patients learned that understanding their underlying Parkinson’s Disease could point toward better options, genetics became a much more prominent community topic.

Results

Eligible research candidates commenced genetic testing across these locations, spanning 48 states. Community outreach beat paid social on what sponsors measure: lower cost per consented and randomized patient, and referrals that were 2.5 times more likely to randomize once they reached site.

That quality came from coordinators who stayed with patients through genetic testing and site scheduling, building enough trust for people to share the campaign in their own networks.

What patients said about the campaign

I never imagined myself joining a research study but you made everything simple and reassuring from the start. Being part of this Parkinson’s community has given me a lot of support. I’m grateful you connected me with others who truly understand what living with Parkinson’s feels like.

Knowing there’s research focused on people like me gives me hope and purpose. I’ve seen so many ads online about clinical trials but finding this study by way of patients sharing your campaign and resources gave me the confidence to move forward when I matched with this opportunity.

I’ve shared your campaign with my network in hopes of connecting others with this incredibly valuable resource. Everyone with Parkinson’s deserves the type of support you’re providing.

Map of WeHealth LRRK2+ referrals across the United States

Want results like these for your trial?

Get a free assessment of your recruitment strategy and see how patient ambassadors can accelerate your enrollment.

Request info

Share your details and we'll follow up about this case study.